Fields »
ABOUT
HELP
BLOG

325 GENES FOUND

Show / hide columns

XML | RDF | TSV | Page of 7 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

 

 

Subcellular location

x

 

 

RNA tissue category

x

 

RNA TS TPM

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 
KNG1Kininogen 1Disease related genes
Plasma proteins
Predicted secreted proteins
Group enrichedkidney:518.0
liver:1860.7
UMODUromodulinDisease related genes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enrichedkidney:2377.1
TMEM174Transmembrane protein 174Predicted membrane proteins
Tissue enrichedkidney:158.0
UGT1A9UDP glucuronosyltransferase 1 family, polypeptide A9Cancer-related genes
Enzymes
Predicted membrane proteins
Group enrichedkidney:461.7
liver:93.2
ACSM2AAcyl-CoA synthetase medium-chain family member 2AEnzymes
Predicted intracellular proteins
Predicted membrane proteins
Group enrichedkidney:284.3
liver:185.7
SLC12A1Solute carrier family 12 (sodium/potassium/chloride transporter), member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enrichedkidney:773.2
SLC22A8Solute carrier family 22 (organic anion transporter), member 8FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enrichedkidney:337.6
HAO2Hydroxyacid oxidase 2 (long chain)Enzymes
Predicted intracellular proteins
Group enrichedkidney:314.9
liver:219.3
BHMTBetaine--homocysteine S-methyltransferaseEnzymes
Plasma proteins
Predicted intracellular proteins
CytosolGroup enrichedkidney:783.3
liver:562.6
SLC22A12Solute carrier family 22 (organic anion/urate transporter), member 12Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Tissue enrichedkidney:104.6
CYP4A11Cytochrome P450, family 4, subfamily A, polypeptide 11Enzymes
Predicted membrane proteins
Group enrichedkidney:230.7
liver:447.9
SLC34A1Solute carrier family 34 (type II sodium/phosphate cotransporter), member 1Disease related genes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enrichedkidney:161.0
SLC22A11Solute carrier family 22 (organic anion/urate transporter), member 11FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Group enrichedepididymis:10.0
kidney:25.9
placenta:44.5
KCNJ1Potassium channel, inwardly rectifying subfamily J, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enrichedkidney:209.0
SLC12A3Solute carrier family 12 (sodium/chloride transporter), member 3Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enrichedkidney:109.3
SLC7A13Solute carrier family 7 (anionic amino acid transporter), member 13Predicted membrane proteins
Transporters
Tissue enrichedkidney:42.6
PRODH2Proline dehydrogenase (oxidase) 2Enzymes
Predicted intracellular proteins
Nucleoplasm
Cytosol		Group enrichedkidney:132.6
liver:45.0
AQP2Aquaporin 2 (collecting duct)Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Group enrichedkidney:432.9
seminal vesicle:299.3
ACSM2BAcyl-CoA synthetase medium-chain family member 2BEnzymes
Predicted intracellular proteins
Predicted membrane proteins
Group enrichedkidney:423.8
liver:261.6
HPD4-hydroxyphenylpyruvate dioxygenaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nuclear specklesGroup enrichedkidney:526.3
liver:1290.5
SLC22A2Solute carrier family 22 (organic cation transporter), member 2Predicted membrane proteins
Transporters
Tissue enrichedkidney:149.2
SLC6A18Solute carrier family 6 (neutral amino acid transporter), member 18Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Tissue enrichedkidney:8.2
NPHS2Nephrosis 2, idiopathic, steroid-resistant (podocin)Disease related genes
Predicted membrane proteins
Tissue enrichedkidney:92.9
SLC22A6Solute carrier family 22 (organic anion transporter), member 6FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enrichedkidney:199.6
SLC22A7Solute carrier family 22 (organic anion transporter), member 7Predicted membrane proteins
Transporters
Group enrichedkidney:50.1
liver:167.4
TMEM207Transmembrane protein 207Predicted membrane proteins
Tissue enrichedkidney:18.5
POU3F3POU class 3 homeobox 3Predicted intracellular proteins
Transcription factors
NucleusGroup enrichedcerebral cortex:36.6
epididymis:34.9
kidney:28.3
seminal vesicle:17.2
SLC22A24Solute carrier family 22, member 24Predicted membrane proteins
Transporters
Tissue enrichedkidney:4.6
SLC22A13Solute carrier family 22 (organic anion/urate transporter), member 13Predicted membrane proteins
Transporters
Tissue enrichedkidney:10.6
DAOD-amino-acid oxidaseEnzymes
Predicted intracellular proteins
Predicted secreted proteins
Group enrichedkidney:89.2
liver:73.8
MCCD1Mitochondrial coiled-coil domain 1Predicted secreted proteins
Tissue enrichedkidney:3.5
DUSP9Dual specificity phosphatase 9Enzymes
Predicted intracellular proteins
Endoplasmic reticulumGroup enrichedkidney:28.9
placenta:102.9
AGXT2Alanine--glyoxylate aminotransferase 2Enzymes
Predicted intracellular proteins
Group enrichedkidney:196.2
liver:59.1
SLC10A2Solute carrier family 10 (sodium/bile acid cotransporter), member 2Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Group enrichedduodenum:21.6
kidney:15.3
small intestine:52.2
DIO1Deiodinase, iodothyronine, type IEnzymes
Predicted intracellular proteins
Predicted membrane proteins
Group enrichedkidney:146.4
liver:94.7
thyroid gland:433.9
MIOXMyo-inositol oxygenaseEnzymes
Predicted intracellular proteins
Tissue enrichedkidney:818.9
FXYD4FXYD domain containing ion transport regulator 4Predicted membrane proteins
Tissue enrichedkidney:126.8
SLC28A1Solute carrier family 28 (concentrative nucleoside transporter), member 1Predicted membrane proteins
Transporters
Group enrichedduodenum:39.0
kidney:49.1
liver:35.4
small intestine:54.7
SLC36A2Solute carrier family 36 (proton/amino acid symporter), member 2Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Group enrichedkidney:67.2
skeletal muscle:28.1
SLC5A10Solute carrier family 5 (sodium/sugar cotransporter), member 10Predicted membrane proteins
Transporters
Tissue enrichedkidney:43.7
ALDH8A1Aldehyde dehydrogenase 8 family, member A1Predicted intracellular proteins
CentrosomeGroup enrichedkidney:73.9
liver:127.6
UPB1Ureidopropionase, betaDisease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Group enrichedkidney:50.8
liver:161.3
ALDOBAldolase B, fructose-bisphosphateCancer-related genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Group enrichedduodenum:3808.7
kidney:6531.8
liver:5081.5
small intestine:5731.3
CLEC18CC-type lectin domain family 18, member CPredicted secreted proteins
Group enrichedkidney:12.2
testis:3.6
CUBNCubilin (intrinsic factor-cobalamin receptor)Disease related genes
Predicted intracellular proteins
Predicted secreted proteins
Group enrichedkidney:152.5
small intestine:55.3
DPYSDihydropyrimidinaseDisease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Group enrichedkidney:199.0
liver:245.6
ERICH4Glutamate-rich 4Predicted intracellular proteins
Nucleoplasm
Cytosol		Group enrichedduodenum:44.1
kidney:16.2
small intestine:43.8
PFN3Profilin 3Predicted intracellular proteins
Group enrichedkidney:1.1
testis:3.2
SLC6A19Solute carrier family 6 (neutral amino acid transporter), member 19Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Group enrichedduodenum:143.3
kidney:91.3
small intestine:160.0
TMEM52BTransmembrane protein 52BPredicted intracellular proteins
Predicted secreted proteins
Focal adhesion sitesTissue enrichedkidney:182.6

Page of 7 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.